Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 30;29(7-8):932-44.
doi: 10.1002/sim.3767.

Checking consistency in mixed treatment comparison meta-analysis

Affiliations

Checking consistency in mixed treatment comparison meta-analysis

S Dias et al. Stat Med. .

Abstract

Pooling of direct and indirect evidence from randomized trials, known as mixed treatment comparisons (MTC), is becoming increasingly common in the clinical literature. MTC allows coherent judgements on which of the several treatments is the most effective and produces estimates of the relative effects of each treatment compared with every other treatment in a network.We introduce two methods for checking consistency of direct and indirect evidence. The first method (back-calculation) infers the contribution of indirect evidence from the direct evidence and the output of an MTC analysis and is useful when the only available data consist of pooled summaries of the pairwise contrasts. The second more general, but computationally intensive, method is based on 'node-splitting' which separates evidence on a particular comparison (node) into 'direct' and 'indirect' and can be applied to networks where trial-level data are available. Methods are illustrated with examples from the literature. We take a hierarchical Bayesian approach to MTC implemented using WinBUGS and R.We show that both methods are useful in identifying potential inconsistencies in different types of network and that they illustrate how the direct and indirect evidence combine to produce the posterior MTC estimates of relative treatment effects. This allows users to understand how MTC synthesis is pooling the data, and what is 'driving' the final estimates.We end with some considerations on the modelling assumptions being made, the problems with the extension of the back-calculation method to trial-level data and discuss our methods in the context of the existing literature.

PubMed Disclaimer

Publication types

MeSH terms

Substances